Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |